Relationship between G-protein beta-3 subunit C825T polymorphism and mirtazapine responses in Korean patients with major depression

Neuropsychobiology

Volumn 56, Issue 1, 2007, Pages 1-5

  Kang, Rhee Hun ^a,b   Hahn, Sang Woo ^c   Choi, Myoung Jin ^a,b   Lee, Min Soo ^a,b,d  

^a Korea University   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Soonchunhyang University College of Medicine   (South Korea)

^d Korea University College of Medicine   (South Korea)

Author keywords

GNB3; Major depressive disorder; Mirtazapine; Polymorphism

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; MIRTAZAPINE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL EVALUATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HAMILTON SCALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL PATIENT; PATHOGENESIS; PRIORITY JOURNAL; STRUCTURED INTERVIEW; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; ASIAN CONTINENTAL ANCESTRY GROUP; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENOTYPE; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; MALE; MIANSERIN; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 36349029742     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109970     Document Type: Article

References (20)

1. Hamm HE: The many faces of G protein signaling. J Biol Chem 1998;273:669-672.
2. Neer EJ: Heterotrimeric G proteins: organizers of transmembrane signals. Cell 1995;80:249-257.
3. Ford CE, Skiba NP, Bae H, Daaka Y, Reuveny E, Shekter LR, et al: Molecular basis for interactions of G protein betagamma subunits with effectors. Science 1998;280:1271-1274.
4. Siffert W, Rosskopf D, Moritz A, Wieland T, Kaldenberg-Stasch S, Kettler N, Hartung K, Beckmann S, Jakobs KH: Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension. J Clin Invest 1995;96:759-766.
5. Zill P, Baghai TC, Zwanzger P, Schüle C, Minov C, Riedel M, Neumeier K, Rupprecht R, Bondy B: Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment. Neuroreport 2000;11:1893-1897.
6. Serretti A, Lorenzi C, Cusin C, Zanardi R, Lattuada E, Rossini D, et al: SSRIs antidepressant activity is influenced by G beta 3 variants. Eur Neuropsychopharmacol 2003;13:117-122.
7. First MB, Spitzer RL, Gibbon M, Willams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders SCID I: Clinician Version, Administration Booklet. Washington, American Psychiatric Press, 1997.
8. Han OS, Hong JP: Structured clinical interview for DSM-IV axis I disorder - Korean version. Seoul, Hana Medical, 2000.
9. Vetulani J, Sulser F: Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain. Nature 1975;257:495-496.
10. Sulser F, Vetulani J, Mobley PL: Mode of action of antidepressant drugs. Biochem Pharmacol 1978;27:257-261.
11. Bergstrom DA, Kellar KJ: Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment. J Pharmacol Exp Ther 1979;209:256-261.
12. Blackshear MA, Sanders-Bush E: Serotonin receptor sensitivity after acute and chronic treatment with mianserin. J Pharmacol Exp Ther 1982;221:303-308.
13. Kendall DA, Nahorski SR: 5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: pharmacological characterization and effects of antidepressants. J Pharmacol Exp Ther 1985;233:473-479.
14. Blier P, de Montigny C: Current advances and trends in the treatment of depression. Trends Pharmacol Sci 1994;15:220-226.
15. Manji HK, Drevets WC, Charney DS: The cellular neurobiology of depression. Nat Med 2001;7:541-547.
16. Joyce PR, Mulder RT, Luty SE, McKenzie JM, Miller AL, Rogers GR, Kennedy MA: Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline. Int J Neuropsychopharmacol 2003;6:339-346.
17. Lee H, Cha J, Ham B, Han C, Kim Y, Lee S, Ryu S, Kang R, Choi M, Lee M: Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders. Pharmacogenomics J 2004;4:29-33.
18. Siffert W: G-protein beta3 subunit C825T allele and hypertension. Curr Hypertens Rep 2003;5:47-53.
19. Bondy B, Baghai TC, Zill P, Bottlender R, Jaeger M, Minov C, et al: Combined action of the ACE D- and the G-protein beta3 T-allele in major depression: a possible link to cardiovascular disease? Mol Psychiatry 2002;7:1120-1126.
20. Kunugi H, Kato T, Fukuda R, Tatsumi M, Sakai T, Nanko S: Association study of C825T polymorphism of the G-protein b3 subunit gene with schizophrenia and mood disorders. J Neural Transm 2002;109:213-218.